Mycophenolate myopathy following liver transplantation: Case report
DOI:
https://doi.org/10.59093/27112330.124Keywords:
myotoxicity, hepatic transplantation, mycophenolic acidAbstract
Drug-induced myopathies are a relatively common cause of acute muscle weakness. In many cases, symptoms begin shortly after initiating the causative medication; however, diagnosis can be challenging due to polypharmacy or the initial association of symptoms with other pathologies. This can lead to a delay in withdrawing the medication, which is essential for treatment. We present the case of a 62-year-old patient with a history of hepatocellular carcinoma who developed acute muscle weakness in the early postoperative period following liver transplantation. An exceptional association with mycophenolate-induced myopathy was documented. Upon discontinuation of this medication, the patient regained full muscle strength, confirming the diagnosis. In fact, this case is the second reported in the medical literature of mycophenolate-induced myopathy.
Downloads
References
Rao A, Nawaz I, Arbi FM, Ishtiaq R. Proximal myopathy: causes and associated conditions. Discoveries (Craiova) 2022;10:e160 https://doi.org/10.15190/d.2022.19.
Pasnoor M, Barohn RJ, Dimachkie MM. Toxic myopathies. Curr Opin Neurol 2018;31:575-582. https://doi.org/10.1097/wco.0000000000000606.
Doughty CT, Amato AA. Toxic myopathies. Continuum (Minneap Minn). 2019;25:1712-1731. https://doi.org/10.1212/con.0000000000000806.
Olivé A. Miopatías farmacógenas. Reumatol Clin 2010;6:25-27. https://doi.org/10.1016/j.reuma.2010.05.002.
Zhao A, Guo D, Zhu M, et al. Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients. Eur J Clin Pharmacol 2024;80:911-918. https://doi.org/10.1007/s00228-024-03662-0.
Silvestri NJ. A Symptoms and signs approach to the patient with neuromuscular weakness. Continuum (Minneap Minn) 2022;28:1580-1595. https://doi.org/10.1212/CON.0000000000001150.
Suresh E, Wimalaratna S. Proximal myopathy: diagnostic approach and initial management. Postgrad Med J 2013;89:470-477. https://doi.org/10.1136/postgradmedj-2013-131752.
Miernik S, Matusiewicz A, Olesińska M. Drug-induced myopathies: A comprehensive review and update. Biomedicines 2024;12:987. https://doi.org/10.3390/biomedicines12050987.
Santos Ó, Marín J, Muñoz O, Mena Á, Guzmán C, Hoyos S, Restrepo JC, Correa G. Trasplante hepático en adultos: estado del arte. Rev Col Gastroenterol 2012;27:21-31.
Villaverde-Piñeiro L, Cachafeiro-Pin AI, Pérez-Castro A, Otero-Logilde A. Rabdomiólisis asociada a antibióticos: revisión bibliográfica de casos. Rev OFIL-ILAPHAR 2022;26:4-8.
Galindo M, Cabello A, Joven B, Alonso A, Carreira P, Porta J, Ricoy JR, Mateo I, Pablos JL. Mycophenolate mofetil induced myopathy in a patient with lupus nephritis. J Rheumatol 2005;32:188-190. https://doi.org/10.1177/1540510X0503200125.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The authors retain all copyright and grant the Colombian Association of Hepatology a non-exclusive right to publish and disseminate their work.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
